Results 21 to 30 of about 26,546 (243)

Clozapine in Treatment-Resistant Schizophrenia and Its Augmentation with Electroconvulsive Therapy in Ultra-Treatment-Resistant Schizophrenia

open access: yesBiomedicines, 2023
Clozapine is considered the gold standard for patients with treatment-resistant schizophrenia (TRS) who have previously tried other antipsychotics at adequate doses (two or more, with at least one being atypical).
Vjekoslav Peitl   +5 more
doaj   +1 more source

Evaluation of Treatment-Resistant Schizophrenia [PDF]

open access: yesSchizophrenia Bulletin, 1997
A systematic approach to the evaluation and characterization of treatment resistance in schizophrenia has become increasingly important since the introduction of clozapine, risperidone, and olanzapine. The need for accurate evaluation will increase with the introduction of the next generation of antipsychotic medications.
R R, Conley, R W, Buchanan
openaire   +2 more sources

No association of rs1065852 and rs3892097 polymorphisms gene CYP2D6 with treatment resistant schizophrenia

open access: yesОбозрение психиатрии и медицинской психологии имени В.М. Бехтерева, 2019
According to modern data, about a third of patients suffering from schizophrenia are considered treatment resistant. The metabolism of about 20% of medicines and mainly psychotropic drugs is caused by the isoenzyme CYP2D6.
D. N. Sosin   +4 more
doaj   +1 more source

Generation of ultra-treatment-resistant schizophrenia patient-derived induced pluripotent stem cell line UJSi002-A

open access: yesStem Cell Research, 2022
Schizophrenia is a chronic, serious and disabling mental disorder. Most patients can effectively control their condition through drug treatment, but there are still some patients who are difficult to gain benefits from drug treatment.
Jing Sun   +7 more
doaj   +1 more source

Clozapine in treatment-resistant schizophrenia [PDF]

open access: yesBritish Journal of Psychiatry, 2017
In an era when 11 meta-analyses are published every day, there are sometimes 2 on the same topic which do not agree. As such a situation can be very confusing, systematic reviewers should discuss their findings in the light of existing reviews to make the differences understandable to readers.[1 ...
Myrto, Samara, Stefan, Leucht
openaire   +2 more sources

Is disorganized schizophrenia a predictor of treatment resistance? Evidence from an observational study

open access: yesBrazilian Journal of Psychiatry, 2013
Objective: To investigate whether inpatients with disorganized schizophrenia are more resistant to treatment. Method: Eighty-five inpatients were assessed at admission and at discharge for schizophrenia subtype, symptom severity, and treatment ...
Bruno Bertolucci Ortiz   +4 more
doaj   +1 more source

Combination of clozapine, cariprazine and fluoxetine in treatment-resistant schizophrenia patient with prominent negative symptoms: A Case report

open access: yesEuropean Psychiatry, 2022
Introduction Despite pharmacological advances in the treatment of schizophrenia, significant number of patients are still treatment-resistant. Clozapine is recommended as first-line treatment for treatment-resistant schizophrenia (TRS) in guidelines ...
I. Everte, A. Pamše-Romāne, M. Taube
doaj   +1 more source

Electroconvulsive Therapy for Treatment-Resistant Schizophrenia [PDF]

open access: yesSchizophrenia Bulletin, 2019
Electroconvulsive therapy (ECT) involves the induction of a seizure by the administration of an electrical stimulus via electrodes usually placed bilaterally on the scalp and was introduced as a treatment for schizophrenia in 1938. However, ECT is a controversial treatment with concerns about long-term side effects such a memory loss.
Diarmid J M, Sinclair   +5 more
openaire   +4 more sources

Strategies in clozapine-resistant schizophrenia: A literature review

open access: yesJournal of Mental Health and Human Behaviour, 2016
Treatment resistance to what is often deemed the last line of schizophrenia treatment, clozapine, is a burgeoning problem in psychiatric practice, with estimates of clozapine resistance standing at 40–70% of the treated population.
Ganesh Kundadak Kudva   +1 more
doaj   +1 more source

Association of DRD2, DRD4 and COMT genes variants and their gene-gene interactions with antipsychotic treatment response in patients with schizophrenia

open access: yesBMC Psychiatry, 2023
Antipsychotic drugs are the first line of treatment in schizophrenia; although antipsychotic responses indicate a wide interindividual variety in patients with schizophrenia.
Narges Taheri   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy